Page 164 - ஸ்டான்போர்ட் பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

As more than two people were dying in the United States every minute from COVID-19, the Food and Drug Administration’s advisory panel voted on Thursday to recommend approval of the first vaccine for emergency use in people 16 and older. Now, the first 2.9 million doses of Pfizer’s COVID-19 vaccine are making their way across the country, with the same number held in reserve for the booster twenty-one days later and another half million banked for unexpected needs. The first doses are expected to go to the nation’s 21 million healthcare workers and 3 million residents of long-term care facilities, while vaccines-on-demand at local pharmacies are bull’s-eyed for April at the earliest.

United statesJason silversteinjason silversteinSonali kochharRobert finbergScott gottliebGrace leeUniversity of montanaDrug administrationStanford university school of medicineHarvard medical schoolDepartment of global healthMen healthUniversity of massachusettsUniversity of washingtonProducts advisory committeePublic affairs research